Trial In Biomedical Stock Scheme Delayed
A federal judge in Massachusetts on Thursday agreed to delay a trial against a former biomedical company executive in an alleged stock scheme, signaling concern over voluminous discovery....To view the full article, register now.
Already a subscriber? Click here to view full article